Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes

Article Abstract:

Mice lacking in the single polypeptide OCA-B were generated through gene targeting to determine the biological role of OCA-B. Mice deficient with OCA-B undergo normal antigen-independent, B-cell differentiation. Antigen-dependent maturation of B cells is highly affected, however. Weak proliferative response to surface IgM crosslinking is noted, as well a severe deficiency in the production of secondary immunoglobulin isotypes in OCA-B-deficient B cells. Germinal center formation is not found in these mutant mice.

Author: Roeder, Robert G., Luo, Yan, Gong, Shiaoching, Nussenzweig, Michel, Stevens, Sean, Kim, Unkyu, Qin, Xiao-Feng
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1996
Genetic aspects, Mice, Mice (Rodents), Genetic transcription, Transcription (Genetics), Immunoglobulin genes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Secondary V(D)J recombination in B-1 cells

Article Abstract:

The self-renewing B-1 B cells are predisposed to auto-antibody production. B-1 cells are shown to express recombinase-activating genes 1 and 2, undergoing secondary V(D)J recombination of immunoglobulin genes. High levels of RAG messenger RNA and recombination were observed in B cells from autoimmune-prone NZB mice. The secondary immunoglobulin-gene rearrangements may have a role in the development of autoreactive antibodies.

Author: Nussenzweig, Andre, Rajewsky, Klaus, Suh, Heikyung, Nussenzweig, Michel C., Qin, Xiao-Feng, Schwers, Stephan, Yu, Wong, Papavasiliou, Fotini
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1999

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Continued RAG expression in late stages of B Cell development and no apparent re-induction after immunization

Article Abstract:

The regulation of RAG expression in transgenic mice with a bacterial artificial chromosome encoding a green fluorescent protein report instead of RAG2 was investigated. The reporter was found to be expressed in all immature B cells in the bone marrow and spleen. Endogenous RAG messenger RNA is expressed in immature B cells, decreasing as they acquire higher rates of surface immunoglobulin M.

Author: Suh, Heikyung, Jankovic, Mila, Nussenzweig, Michel C., Melchers, Fritz, Rolink, Antonius, Yu, Wong, Nagaoka, Hitoshi, Misulovin, Ziva, Meffre,Eric
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1999
Immune system

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, B cells
Similar abstracts:
  • Abstracts: B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. In vivo imaging of germinal centres reveals a dynamic open structure
  • Abstracts: The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
  • Abstracts: Smart transcription factors. Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice
  • Abstracts: The professional in endangered species conservation: an introduction to standpoint clarification. Endangered species conservation in Australia: a partial review and recommendations
  • Abstracts: Dimeric ligands define a role for transcriptional activation domains in reinitiation. Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.